NYSE

Equifax, Inc. (EFX)

370 Thanks from members

Equifax, Inc. (EFX) displays a divided sentiment profile, balancing strong Q2 2026 revenue growth and aggressive AI cost targets against margin pressures, legal accruals, and mixed retail-versus-institutional conviction.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →